Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTRS Viatris Inc.

交易中 08-13 15:13:35 EDT

16.11

+0.01

+0.03%

最高16.38	最低16.08	成交量671.91万
今开16.28	昨收16.10	日振幅1.86%
总市值185.05亿	流通市值184.08亿	总股本11.49亿
成交额1.09亿	换手率0.59%	流通股本11.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTRS","market":"US","secType":"STK","nameCN":"Viatris Inc.","latestPrice":16.105,"timestamp":1786648415083,"preClose":16.1,"halted":0,"volume":6719094,"delay":0,"changeRate":0.00031055900621111834,"floatShares":1143000000,"shares":1149000000,"eps":-0.354341,"marketStatus":"交易中","change":0.005,"latestTime":"08-13 15:13:35 EDT","open":16.28,"high":16.38,"low":16.08,"amount":109281427.73514,"amplitude":0.018634,"askPrice":16.11,"askSize":1598,"bidPrice":16.1,"bidSize":2252,"shortable":3,"etf":0,"ttmEps":-0.354341,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786651200000},"marketStatusCode":2,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":16.1,"dividendRate":0.029804,"preHourTrading":{"tag":"盘前","latestPrice":16.33,"preClose":16.1,"latestTime":"09:29 EDT","volume":2482,"amount":40276.977660000004,"timestamp":1786627799999,"change":0.23,"changeRate":0.014286,"amplitude":0.027329},"postHourTrading":{"tag":"盘后","latestPrice":16.02,"preClose":16.1,"latestTime":"19:42 EDT","volume":4656871,"amount":74975583.5481,"timestamp":1786578125799,"change":-0.08,"changeRate":-0.004969,"amplitude":0.008696},"volumeRatio":0.517285,"impliedVol":0.2949,"impliedVolPercentile":0.1952},"requestUrl":"/m/hq/s/VTRS","defaultTab":"news","newsList":[{"id":"1122412008","title":"异动解读 | Viatris盘中大跌5.04%，Q2业绩超预期但遭遇利好兑现获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1122412008","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122412008?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:22","pubTimestamp":1786036952,"startTime":"0","endTime":"0","summary":"Viatris Inc.今日盘中大幅下挫5.04%，引发市场广泛关注。尽管财报数据表现亮眼，但股价在盘前短暂上涨1.08%后迅速转跌，呈现典型的“利好兑现”后获利回吐走势。公司此前已连续三个季度业绩超预期，叠加年内股价自低位已有显著涨幅，市场选择在业绩兑现节点锁定收益，导致盘中跌幅持续扩大。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128204486","title":"异动解读｜Viatris盘中下跌5.01%，Q2业绩超预期但遭获利了结","url":"https://stock-news.laohu8.com/highlight/detail?id=1128204486","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128204486?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:21","pubTimestamp":1786036896,"startTime":"0","endTime":"0","summary":"8月6日，Viatris盘中下跌5.01%，报16.765美元/股，成交额1.39亿美元。消息面上，公司当日盘前公布Q2财报：调整后每股收益0.69美元，超出市场预期的0.60美元达15%；营收37.56亿美元，高于预期的36.75亿美元。尽管业绩全面超预期且指引上调，但股价在盘前短暂上涨1.08%后迅速转跌，呈现典型的利好兑现后获利回吐走势。公司此前已连续三个季度超预期，叠加年内股价自低位已有显著涨幅，市场选择在业绩兑现节点锁定收益。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133818177","title":"特朗普药品关税计划引发关注：药价、药企与供应链将受何影响？","url":"https://stock-news.laohu8.com/highlight/detail?id=1133818177","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133818177?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:56","pubTimestamp":1784732210,"startTime":"0","endTime":"0","summary":"特朗普拟对进口仿制药实施最高200%的关税，引发市场对药价上涨、供应链重构及药企盈利的担忧。业内人士认为，两年缓冲期为企业调整产能提供了窗口，但政策细则仍待明确，最终影响将取决于关税实施范围及美国本土制造认定标准，不同药企面临的冲击或将明显分化。","market":"us","thumbnail":"https://static.tigerbbs.com/556186869d2b495debe9035461bacadc","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/556186869d2b495debe9035461bacadc"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"特朗普药品关税计划引发关注：药价、药企与供应链将受何影响？","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","VTRS","AMPH","ANIP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1105720351","title":"Viatris公布Vr-205治疗日本成人原发性免疫球蛋白A肾病三期研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1105720351","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105720351?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:59","pubTimestamp":1782730767,"startTime":"0","endTime":"0","summary":"Viatris Inc. 近日宣布，其候选药物Vr-205在日本成人原发性免疫球蛋白A肾病患者中开展的三期临床研究，已获得积极的顶线结果。该研究达到了预设的主要终点，数据表明Vr-205在目标患者群体中展现出良好的疗效与安全性特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU2087621335.USD","VTRS","LU1839511570.USD","BK4007","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114542416","title":"澳大利亚TGA：Viatris将继续在澳获得所有规格Creon的常规供应；供应量可能受限","url":"https://stock-news.laohu8.com/highlight/detail?id=1114542416","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114542416?lang=zh_cn&edition=full","pubTime":"2026-06-11 14:28","pubTimestamp":1781159299,"startTime":"0","endTime":"0","summary":"澳大利亚药品管理局（TGA）确认，Viatris Inc. 将继续在澳大利亚市场获得其所有规格的Creon胰酶制剂的常规供应。\n然而，该监管机构同时指出，这些产品的供应量在未来一段时间内可能受到限制，存在供应紧张的可能性。Viatris公司作为Creon在澳大利亚的供应商，将继续维持其供应链的运转。\nTGA的声明旨在缓解市场对Creon可能断供的担忧，同时提示医疗专业人员和患者，在获取某些规格的药品时可能会遇到延迟或数量限制的情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","VTRS","BK4007","BK4588","LU1839511570.USD","BK4583","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151742930","title":"澳大利亚TGA：全球需求意外激增，导致Creon胰酶制剂供应受限","url":"https://stock-news.laohu8.com/highlight/detail?id=1151742930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151742930?lang=zh_cn&edition=full","pubTime":"2026-06-11 14:28","pubTimestamp":1781159299,"startTime":"0","endTime":"0","summary":"澳大利亚治疗商品管理局（TGA）发布通告称，由于全球范围内对Creon胰酶制剂的需求出现意外增长，目前该药品的供应正面临限制。\n这一供应紧张局面源于市场需求超出预期，导致生产与分销环节出现瓶颈。相关药品的供应保障工作正面临挑战。\n作为Creon的制造商之一，Viatris Inc. 的供应情况可能因此受到影响。目前，监管机构与相关企业正密切关注事态发展，并努力协调以缓解供应压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4583","BK4007","LU2087621335.USD","VTRS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193216760","title":"异动解读 | 业绩超预期叠加中国业务强劲，Viatris盘前大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193216760","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193216760?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:29","pubTimestamp":1778164162,"startTime":"0","endTime":"0","summary":"Viatris Inc. (VTRS) 今日盘前股价大幅上涨5.27%，表现亮眼。消息面上，公司公布的第一季度业绩超出市场预期，营收和利润均超分析师预估。这主要得益于其在中国市场的强劲表现以及品牌药品（如立普妥、诺瓦斯克）销售的旺盛需求。此外，公司高管在近期电话会议中透露，对2026年大中华区业务发展持乐观态度，预计该市场营收将实现中高个位数增长，进一步增强了市场信心。公司不仅重申了2026年的盈利和营收预测，其在中国及多个新兴市场的增长也超出了预期，展现了公司核心业务的稳定性与增长潜力。这些积极因素共同推动了股价在盘前交易时段的大幅上扬。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129013509","title":"Viatris高管预计2026年大中华区营收将实现中高个位数增长——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1129013509","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129013509?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:55","pubTimestamp":1778158542,"startTime":"0","endTime":"0","summary":"Viatris公司高管在近期电话会议中透露，集团对2026年大中华区业务发展持乐观态度，预计该市场营收将呈现中高个位数的增长态势。这一预测彰显了公司对亚太区域战略布局的信心，同时也反映出中国医药市场持续释放的增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4007","VTRS","LU1839511570.USD","LU2087621335.USD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120683557","title":"财报前瞻｜Viatris Inc.本季度营收预计增3.77%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1120683557","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120683557?lang=zh_cn&edition=full","pubTime":"2026-04-30 11:29","pubTimestamp":1777519786,"startTime":"0","endTime":"0","summary":"Viatris Inc.将于2026年05月07日盘前发布最新季度财报，市场预期关注收入与每股收益的同比变化及全年指引兑现度。市场一致预期本季度收入为33.57亿美元，同比增长3.77%；调整后每股收益为0.50美元，同比增长2.61%；息税前利润为8.35亿美元，同比下降0.36%。公司未披露分业务营收与同比细分数据，当前看点集中在美国处方渠道覆盖与价格策略的协同带动处方量。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Viatris Inc.本季度营收预计增3.77%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164782158","title":"Viatris在日本获批Effexor®用于成人广泛性焦虑症治疗 创新产品组合再获突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1164782158","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164782158?lang=zh_cn&edition=full","pubTime":"2026-03-23 19:00","pubTimestamp":1774263618,"startTime":"0","endTime":"0","summary":"Viatris Inc.宣布其抗焦虑药物Effexor®正式获得日本监管机构批准，适用于成人广泛性焦虑症（GAD）的治疗。此次获批标志着该公司创新产品组合的战略推进取得重要进展。\n该药物在日本市场的准入将为企业拓展神经精神疾病治疗领域提供新的增长动能，同时强化Viatris在亚太地区专科药物市场的布局。此次获批也体现了公司持续通过引入差异化治疗方案来满足临床未竟需求的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4583","VTRS","BK4585","BK4007","BK4588","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132079552","title":"Viatris展望2030年：调整后每股收益复合年增长率预计达9%-10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132079552","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132079552?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:59","pubTimestamp":1773925159,"startTime":"0","endTime":"0","summary":"Viatris Inc.近日发布长期业绩指引，预计到2030年，公司调整后每股收益的复合年增长率将维持在9%至10%的区间。这一预测展现了管理层对未来盈利能力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2087621335.USD","VTRS","LU1839511570.USD","BK4583","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132408834","title":"GoodRx Holdings, Inc.：现金支付消费者可在全美逾7万家药房享受最高85%折扣","url":"https://stock-news.laohu8.com/highlight/detail?id=1132408834","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132408834?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:03","pubTimestamp":1773234207,"startTime":"0","endTime":"0","summary":"GoodRx Holdings, Inc. 宣布，通过其平台，使用现金支付的消费者可在全美超过70,000家药房享受高达85%的药品折扣。这一服务旨在帮助没有医疗保险或选择自费购药的人群降低医疗成本。\n目前，GoodRx已与多家大型药房连锁品牌合作，覆盖范围广泛。用户只需在购药时出示GoodRx提供的优惠码，即可直接享受价格减免。公司表示，此举将有效缓解部分民众的用药经济压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4585","LU1839511570.USD","BK4588","VTRS","LU2087621335.USD","GDRX","BK4007","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103779517","title":"Viatris首席执行官透露11月与FDA就印多尔工厂进展进行会谈，预计今年内准备就绪迎接复查但具体时间由FDA决定——电话会议信息","url":"https://stock-news.laohu8.com/highlight/detail?id=1103779517","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103779517?lang=zh_cn&edition=full","pubTime":"2026-02-26 21:47","pubTimestamp":1772113661,"startTime":"0","endTime":"0","summary":"Viatris Inc. 首席执行官在近期电话会议中透露，公司已于去年11月与美国食品药品监督管理局（FDA）会面，专题汇报印度印多尔工厂的整改进展。首席执行官明确表示，该工厂将在今年内全面准备就绪，以迎接FDA的再次现场检查，但具体复查时间安排仍取决于监管机构的日程规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1839511570.USD","VTRS","LU2087621335.USD","BK4007","BK4583","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165038494","title":"Viatris公司预计重组活动及相关成本节约将在未来三年内基本完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1165038494","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165038494?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:27","pubTimestamp":1772108863,"startTime":"0","endTime":"0","summary":"Viatris公司表示，其当前推行的重组计划、相关的成本支出以及预期实现的节约效益，预计将主要在接下来的三年时间内完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4583","LU2087621335.USD","VTRS","BK4007","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147503203","title":"Viatris Inc.重组计划全面实施后，预计可节省6亿至7亿美元成本","url":"https://stock-news.laohu8.com/highlight/detail?id=1147503203","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147503203?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:26","pubTimestamp":1772108794,"startTime":"0","endTime":"0","summary":"Viatris Inc.宣布，其正在推进的重组活动一旦全面落地，有望为公司带来6亿至7亿美元的成本节约。这一举措旨在优化运营效率，提升长期盈利能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4585","BK4588","BK4007","BK4583","VTRS","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138093737","title":"异动解读 | Viatris Inc.宣布重组计划，预计产生高额费用，股价盘前大跌7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138093737","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138093737?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:24","pubTimestamp":1772108680,"startTime":"0","endTime":"0","summary":"Viatris Inc.（股票代码：VTRS）今日盘前股价大幅下跌7.34%，引起了市场的广泛关注。消息面上，公司近日宣布启动企业重组行动，预计将产生总额在7亿美元至8.5亿美元之间的税前费用。这一重大开支计划可能影响了投资者对公司短期财务表现的预期，从而导致了股价的下挫。公司表示，此次重组旨在优化运营结构，以提升长期竞争力，但市场对此短期成本的反应较为负面。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120213946","title":"Viatris纳西克工厂因二月火灾暂时停产，预计2026年4月起逐步恢复运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1120213946","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120213946?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:24","pubTimestamp":1772108658,"startTime":"0","endTime":"0","summary":"全球医疗健康公司Viatris Inc.近日披露，其位于印度纳西克的制药生产基地因今年二月发生的火灾事故，目前已暂停生产活动。该公司表示，正全力推进设施修复与安全评估工作，预计最早将于2026年4月启动阶段性复产。\n此次停产主要影响该工厂特定生产线的运作，Viatris已启动业务连续性计划，通过全球供应链网络协调产能，以最大程度降低对产品供应的冲击。公司强调，将严格遵循当地监管要求，在确保安全合规的前提下有序恢复生产。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4007","VTRS","LU1839511570.USD","LU2087621335.USD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113564178","title":"Viatris Inc.启动重组计划，预计税前费用总额介于7亿至8.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113564178","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113564178?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:23","pubTimestamp":1772108631,"startTime":"0","endTime":"0","summary":"Viatris Inc.近日宣布启动企业重组行动，预计将产生总额在7亿美元至8.5亿美元之间的税前费用。这一举措旨在优化公司运营结构，提升长期竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4583","BK4007","LU2087621335.USD","VTRS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187751292","title":"财报前瞻 ｜Viatris Inc.本季度营收预计降2.27%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1187751292","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187751292?lang=zh_cn&edition=full","pubTime":"2026-02-19 11:16","pubTimestamp":1771470989,"startTime":"0","endTime":"0","summary":"Viatris Inc.将于2026年02月26日发布最新季度财报，市场关注营收与利润承压的幅度及新品放量节奏对整体业绩的影响。公司目前的主营业务在整体口径上展现出韧性：上季度营收为37.60亿美元，同比增长0.23%，毛利率为39.84%，在价格压力背景下维持较为稳定的盈利质量。结合主营盘面的口径数据，上季度营收37.60亿美元、同比增长0.23%，在毛利率39.84%的配合下，显示存量品类与定价策略对现金创造能力仍具支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻 ｜Viatris Inc.本季度营收预计降2.27%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517455736","title":"杰富瑞投资银行：维持Viatris(VTRS.US)评级，由买入调整至买入评级, 目标价由15.00美元调整至13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517455736","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517455736?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:22","pubTimestamp":1741368127,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：维持Viatris(VTRS.US)评级，由买入调整至买入评级, 目标价由15.00美元调整至13.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08012248604905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VTRS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viatris.com;investor.viatris.com","stockEarnings":[{"period":"1week","weight":-0.0878},{"period":"1month","weight":-0.0177},{"period":"3month","weight":-0.0672},{"period":"6month","weight":0.0209},{"period":"1year","weight":0.5909},{"period":"ytd","weight":0.2932}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0311},{"period":"3month","weight":0.0325},{"period":"6month","weight":0.1331},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viatris Inc.于2019年2月14日在特拉华州成立。该公司是一家全球性的医疗保健公司，该公司认为他们具有独特的定位，可以弥合仿制药和品牌之间的传统鸿沟，将两者的优点结合起来，以更全面地满足全球范围内的医疗保健需求。Viatris的使命是赋能世界各地的人们在生命的每个阶段都能过上更健康的生活，大规模地提供准入服务，目前每年为全球约10亿患者提供高质量的药物，并触及生命的所有时刻，从出生到生命的尽头，从急性病到慢性病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.024969},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.073864},{"month":3,"riseRate":0,"avgChangeRate":-0.068903},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.014515},{"month":5,"riseRate":0.666667,"avgChangeRate":0.060472},{"month":6,"riseRate":0.5,"avgChangeRate":-0.02049},{"month":7,"riseRate":0.5,"avgChangeRate":0.03071},{"month":8,"riseRate":0.666667,"avgChangeRate":0.028643},{"month":9,"riseRate":0,"avgChangeRate":-0.072997},{"month":10,"riseRate":0.4,"avgChangeRate":0.02449},{"month":11,"riseRate":0.8,"avgChangeRate":0.040541},{"month":12,"riseRate":0.833333,"avgChangeRate":0.086301}],"exchange":"NASDAQ","name":"Viatris Inc.","nameEN":"Viatris Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viatris Inc.(VTRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viatris Inc.,VTRS,Viatris Inc.股票,Viatris Inc.股票老虎,Viatris Inc.股票老虎国际,Viatris Inc.行情,Viatris Inc.股票行情,Viatris Inc.股价,Viatris Inc.股市,Viatris Inc.股票价格,Viatris Inc.股票交易,Viatris Inc.股票购买,Viatris Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viatris Inc.(VTRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}